Stéphane Bancel is the founder of Moderna Therapeutics. Moderna Therapeutics has raised $650M in total funding. Latest round: Series G.
Stéphane Bancel is the President and CEO of Moderna Therapeutics, a company pioneering messenger RNA (mRNA) Therapeutics. Moderna focuses on developing an entirely new in vivo drug technology that produces human proteins, antibodies, and novel protein constructs inside patient cells. The company has secured over $950 million in funding through financing activities and commercial partnerships by 2015, and a total of $650 million across four funding rounds by 2018. Moderna was founded in 2011 by Flagship VentureLabs.
Full founder directory · Investor directory · Company funding database · Fundraising library